JOHNSON & JOHNSON LAB — Standard BioTools Inc

Ownership history in JOHNSON & JOHNSON  ·  8 quarters on record

AI Ownership Summary

JOHNSON & JOHNSON reported Standard BioTools Inc (LAB) in 8 quarterly 13F filings from 2024 Q1 through 2025 Q4. Peak portfolio weight reached 0.14% in 2024 Q4. The latest visible filing shows LAB at 0.07% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings.

What this LAB ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was JOHNSON & JOHNSON's position in Standard BioTools Inc, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2025 Q4

LAB was reported at 0.07% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.14% in 2024 Q4

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2024 Q1 to 2025 Q4

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

LAB stock page JOHNSON & JOHNSON fund profile JOHNSON & JOHNSON full holdings
How JOHNSON & JOHNSON held LAB — position size vs. price
% of Fund (quarterly)    LAB price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 8 quarters  ▾
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2025 Q4 UNCHANGED — — — 311,967 — 0% 0.07% $399K 2026-02-14 (Est.) $1.12
2025 Q3 UNCHANGED — — — 311,967 — 0% 0.08% $406K 2025-11-13 $1.20
2025 Q2 UNCHANGED — — — 311,967 — 0% 0.11% $371K 2025-07-22 $1.36
2025 Q1 UNCHANGED — — — 311,967 — 0% 0.10% $337K 2025-05-07 $1.02
2024 Q4 UNCHANGED — — — 311,967 — 0% 0.14% $546K 2025-02-13 $1.33
2024 Q3 UNCHANGED — — — 311,967 — 0% 0.14% $602K 2024-11-13 $1.84
2024 Q2 UNCHANGED — — — 311,967 — 0% 0.14% $552K 2024-08-09 $1.62
2024 Q1 INITIATED — — — 311,967 — — 0.02% $845K 2024-05-10 $2.40

🏢 Other funds also holding LAB

As of 2026 Q1 — sorted by position size

Peapod Lane Capital LLC 1.53% Intellectus Partners, LLC 3Y 7Y 0.08% STALEY CAPITAL ADVISERS INC 3Y 7Y 0.02% R Squared Ltd 0.01% Platform Technology Partners 3Y 0.0% DLK Investment Management, LLC 0.0% OPPENHEIMER & CO INC 3Y 7Y 0.0% Abel Hall, LLC 0.0% VSM Wealth Advisory, LLC 0.0% Police & Firemen's Retirement System of New Jersey 0.0%

FAQ About JOHNSON & JOHNSON and LAB

These are the practical questions this page is built to answer before you even open the full history table.

How long has JOHNSON & JOHNSON reported owning LAB?

JOHNSON & JOHNSON reported LAB across 8 quarterly 13F filings, from 2024 Q1 through 2025 Q4.

What was the largest reported LAB position in JOHNSON & JOHNSON's portfolio?

The largest reported portfolio weight for LAB was 0.14% in 2024 Q4.

What is the latest reported LAB position on this page?

The most recent filing on this page is 2025 Q4, when JOHNSON & JOHNSON reported 311,967 shares, equal to 0.07% of portfolio, with an estimated market value of $399K.

What does the chart on this LAB ownership page compare?

The chart compares JOHNSON & JOHNSON's quarterly LAB portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

← Back to JOHNSON & JOHNSON Holdings